Exact Mass: 305.02839919999997
Exact Mass Matches: 305.02839919999997
Found 187 metabolites which its exact mass value is equals to given mass value 305.02839919999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sertraline
Sertraline is a selective serotonin uptake inhibitor that is used in the treatment of depression. Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day. Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder. A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. A selective serotonin uptake inhibitor that is used in the treatment of depression.; Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991.; Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day.; Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder.; A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. [HMDB] N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent CONFIDENCE standard compound; INTERNAL_ID 8627 CONFIDENCE standard compound; INTERNAL_ID 1500 D049990 - Membrane Transport Modulators
Cyclic cmp
Acquisition and generation of the data is financially supported in part by CREST/JST.
Cytidine 2',3'-cyclic phosphate
2,4-Dinitro-3-nitrodiphenyl ether
C12H7N3O7 (305.02839919999997)
4-(beta-D-Ribofuranosyl)aniline 5-phosphate
C11H16NO7P (305.06643560000003)
Acyclovir monophosphate
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
Cepharadione A
Cepharadione A is found in herbs and spices. Cepharadione A is an alkaloid from Piper auritum (Veracruz pepper Alkaloid from Piper auritum (Veracruz pepper). Cepharadione A is found in herbs and spices.
3-((5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl)methyl)pyridine
Acyclovir monophosphate
Cifostodine
2-Aminomethyl-4-t-butyl-6-iodophenol
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Sealdin
C17H17Cl2N (305.07379820000006)
Oxoxylopine
Oxoxylopine, also known as lanuginosine, is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. Oxoxylopine is practically insoluble (in water) and a strong basic compound (based on its pKa). Oxoxylopine can be found in cherimoya, custard apple, and sugar apple, which makes oxoxylopine a potential biomarker for the consumption of these food products.
12-methoxy-8H-benzo[g][1,3]benzodioxolo[6,5,4-de]quinolin-8-one
dimethyl 2,6-dimethyl-4-(2-thienyl)pyridine-3,5-dicarboxylate
5-[(E)-(6-Bromo-1H-indole-3-yl)methylene]imidazolidine-2,4-dione
Sertraline
C17H17Cl2N (305.07379820000006)
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
2,3 Cyclic CMP
Cepharadione A
Sodium risedronate
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Toluidine Blue
D006401 - Hematologic Agents > D003029 - Coagulants > D006494 - Heparin Antagonists D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D004396 - Coloring Agents
2-(1,3-benzoxazol-2-yl)-1-[4-(trifluoromethyl)phenyl]ethanone
2-(1,3-benzoxazol-2-yl)-1-[3-(trifluoromethyl)phenyl]ethanone
azure b
An organic chloride salt having 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ium as the counterion. It is used in making azure eosin stains for blood smear staining and is an active metabolite of methylene blue. D004396 - Coloring Agents > D001399 - Azure Stains
5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt
2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate
C11H13BrClNO2 (304.98181280000006)
2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline
3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
tert-butyl N-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]carbamate
C13H17Cl2NO3 (305.05854320000003)
2-([(4-CHLOROPHENYL)SULFONYL]AMINO)-4-METHYLPENTANOIC ACID
C12H16ClNO4S (305.04885260000003)
2-PHENYL-4-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE
C16H10F3NS (305.04860160000004)
ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE
C9H12BrN3O4 (305.00111319999996)
4-(3-chloro-2-fluoroanilino)-6-hydroxy-1H-quinazolin-7-one
isopropyl N-[chloro(phenoxy)phosphoryl]-L-alaninate
2-BROMO-3-CHLOROPHENYL N,N-DIETHYLCARBAMATE
C11H13BrClNO2 (304.98181280000006)
4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride
n-t-butyl 3-bromo-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
tert-Butyl 3-(2-bromoacetyl)piperidine-1-carboxylate
C12H20BrNO3 (305.0626470000001)
ethyl 4-chloro-5-(ethoxycarbonyloxy)-2-fluorophenylcarbamate
6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine
7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID
2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine
ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE
3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
2-Bromo-1-(1-Boc-piperidin-4-yl)ethanone
C12H20BrNO3 (305.0626470000001)
4-CHLORO-1-(4-METHOXYBENZYL)-1H-IMIDAZO[4,5-C]PYRIDINE-2(3H)-THIONE
2-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
Ammonium anthraquinone-1-sulfonate
C14H11NO5S (305.03579160000004)
2-[[(4-Methylphenyl)sulfonyl]amino]benzoic acid methyl ester
ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE
C10H9Cl2N3O4 (304.99700939999997)
3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-ylidene]hydroxylamine
[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
C11H16BrNO2S (305.00850560000003)
3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol
4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
(4-cyano-3,5-difluorophenyl) 4-ethyl-2-fluorobenzoate
2-(4-FLUOROPHENYL)-2-HYDROXY-4,4-DIMETHYL-1,4-OXAZINAN-4-IUM BROMIDE
(2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOL-5-YL)METHANOL
9-Bromo-2,3,5,6,13,13a-hexahydro-1H-benzo[4,5]imidazo[1,2-d]pyrrolo[1,2-a][1,4]diazepine
(s)-3-amino-4-pentafluorophenylbutanoic acid hydrochloride
7-Benzyl-4-chloro-2-(methylthio)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine
5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
(r)-3-amino-4-pentafluorophenylbutanoic acid hydrochloride
1-Chloro-4-[Isocyano[(4-Methylphenyl)Sulfonyl]Methyl]-Benzene
(6-methyl-1H-indol-2-yl)boronic acid
C12H14Cl3N3 (305.02532540000004)
3-Bromo-N-butyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
2-[2-(4-Bromophenoxy)ethyl]-5-ethylpyridine Hydrogen Sulfate Salt
2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL
3-bromo-N,N-diethyl-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
tert-butyl 4-(1-bromo-2-oxoethyl)piperidine-1-carboxylate
C12H20BrNO3 (305.0626470000001)
3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
6-(3-CHLORO-4-FLUOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
C16H13ClFNO2 (305.06188000000003)
6-(3-CHLORO-5-FLUOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
C16H13ClFNO2 (305.06188000000003)
ethyl 5-(ethoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate
C10H15N3O6S (305.06815300000005)
N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid
C13H7NO6S (304.99940820000006)
2-Chloro-3-methyl-4-[(7R,7AS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]benzonitrile
2,3-cyclic UMP(1-)
C9H10N2O8P- (305.01747700000004)
A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.
N-[[[oxo(thiophen-2-yl)methyl]hydrazo]-sulfanylidenemethyl]benzamide
5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester
N-(4,6-difluoro-1,3-benzothiazol-2-yl)benzohydrazide
2-chloro-N-[4-[(3,4-dimethylphenyl)thio]phenyl]acetamide
9-(2-furyl)-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one
(1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
C17H17Cl2N (305.07379820000006)
(Glycolato-O,O)diammineplatinum(II)
D000970 - Antineoplastic Agents
(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate
C11H16NO7P (305.06643560000003)
dCMP dianion
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)
[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] phosphate
2-[[[(5-Chloro-2-pyridinyl)amino]-oxomethyl]amino]benzoic acid methyl ester
4-nitro-N-[(thiophen-2-ylacetyl)oxy]benzenecarboximidamide
C13H11N3O4S (305.04702460000004)
4-[1-(4-fluorophenyl)ethyl]-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione
1-(3-Methylphenyl)-3-[[(5-methyl-3-thiophenyl)-oxomethyl]amino]thiourea
3-[(2-Chloro-4-fluorophenoxy)methyl]-1,2,3-benzotriazin-4-one
1-(2-Methylphenyl)-3-[[(5-methyl-3-thiophenyl)-oxomethyl]amino]thiourea
N-(3,4-dichlorophenyl)-6-(1-imidazolyl)-3-pyridazinamine
1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide
1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one(1-)
A phenolate anion resulting from the removal of a proton from one of the hydroxy groups of 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one (DIF-1). The major structure at pH 7.3.
2-Chloro-10-phenothiazinecarboxylic acid ethyl ester
2-Amino-3-(3-methoxy-4-sulfooxyphenyl)-2-methylpropanoic acid
4-(beta-D-ribofuranosyl)aminobenzene 5-phosphate
C11H16NO7P (305.06643560000003)
4-amino-1-[2-hydroxy-6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidin-2(1H)-one
2,3-cyclic CMP
A 2,3-cyclic pyrimidine nucleotide in which cytidine is the parent nucleoside.
2-deoxycytosine 5-monophosphate(2-)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-deoxycytidine 5-monophosphate (dCMP); major species at pH 7.3.
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].